Last checked at | Director Dealings Summary - Week Ended April 10 | ||||||||||||
| Company | Name | Position | Number of Shares | Resulting Holding | *Note | GBP Value | ||||||
| BUYS | ||||||||||||
| Hutchison China MediTech | Simon To | Chairman | 58,000 | 127,000 | 800,000 | |||||||
| Strategic Minerals | John Peters | Chairman | 1 million | 1 million | First purchase. | 600,000 | ||||||
| Hutchison China MediTech | Edith Shih | Non-Executive Director | 12,000 | 60,000 | 166,000 | |||||||
| Hydrodec | Andrew Black | Non-Executive Director | 1,750,000 | 183.6 million | Day after Hydrodec agreed to buy Eco-Oil International for GBP2.4 million. | 121,000 | ||||||
| Dunedin Enterprise Investment Trust | Duncan Budge | Chairman | 20,000 | 35,900 | Week after making GBP5 million investment in Blackrock Programme Management. | 68,000 | ||||||
| Amerisur Resources | John Wardle | CEO | 248,000 | 17.6 million | Purchased by Tracarta in which Wardle has a beneficial interest. | 60,000 | ||||||
| Amerisur Resources | Douglas Ellenor | Non-Executive Director | 200,000 | 1.2 million | Same day as pretax profit fell during 2014 and revenue was offset by impairment charge. | 50,000 | ||||||
| Chime Communications | Mervyn Davies | Chairman | 17,936 | 67,785 | 50,000 | |||||||
| Synety | Graham Ward | Non-Executive Director | 28,075 | 234,870 | 2 days after share placing and open offer. | 25,000 | ||||||
| JPMorgan Brazil Investment Trust | Victor Bulmer-Thomas | Non-Executive Director | 43,750 | 159,850 | 24,000 | |||||||
| Hydrodec | Colin Moynihan | Chairman | 310,155 | 10.2 million | Day after Hydrodec agreed to buy Eco-Oil International for GBP2.4 million. | 20,000 | ||||||
| Xaar | Edmund Creutzmann | CTO | 4,846 | 4,846 | First purchase. | 20,000 | ||||||
| Dunedin Enterprise Investment Trust | Federico Marescott | Director | 6,000 | 10,000 | Week after making GBP5 million investment in Blackrock Programme Management. | 20,000 | ||||||
| Synectics | Peter Rae | Non-Executive Director | 14,000 | 232,302 | 18,000 | |||||||
| Michelmersh | Frank Hanna | Commercial Director | 21,985 | 1.3 million | 2 weeks after reinstating its dividend payout. | 15,000 | ||||||
| Hydrodec | Ian Smale | CEO | 200,000 | 1.1 million | Day after Hydrodec agreed to buy Eco-Oil International for GBP2.4 million. | 14,000 | ||||||
| Amerisur Resources | Nick Harrison | CFO | 50,000 | 5.7 million | Same day as pretax profit fell during 2014 and revenue was offset by impairment charge. | 12,000 | ||||||
| Standard Life | Elizabeth Noel Harwerth | Non-Executive Director | 1,893 | 10,074 | 8,900 | |||||||
| Concurrent Technologies | David Evans-Hughes | Engineering Director | 8,755 | 948,206 | 3,900 | |||||||
| SELLS | ||||||||||||
| Amec Foster Wheeler | Kent Masters | Non-Executive Director | 347,273 | 70,000 (in the form of ADRs) | Week after winning EDF Energy UK nuclear power station deal. | 3,800,000 | ||||||
| CVS Group | Simon Innes | CEO | 300,000 | 246,475 | Sold more than half his stake. | 1,700,000 | ||||||
| Domino Printing Sciences | Peter Byrom | Chairman | 11,932 | 338,000 | 111,000 | |||||||
| *Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event. When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director. | ||||||||||||
| Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam | ||||||||||||
| Copyright 2015 Alliance News Limited. All Rights Reserved. | ||||||||||||
20 Jan 2022 11:03
Hutchmed begins phase one study for potential tumour treatment
Hutchmed begins phase one study for potential tumour treatment
Read more